J A Allen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J A Allen

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Mutagenesis|September 1, 1992

Report of British Toxicology Society/UK Environmental Mutagen Society Working Group. Dose setting in in vivo mutagenicity assaysR J Fielder, J A Allen, A R Boobis, et al.

Neuro-Ophthalmology (Aeolus Press)|February 8, 2017

Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating PolyradiculoneuropathyS J Hickman, J A Allen, A Baisre, et al.

Cell Death and Differentiation|September 17, 2013

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesisS R Chan, C G Rickert, W Vermi, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Mutagenesis|September 1, 1992

Report of British Toxicology Society/UK Environmental Mutagen Society Working Group. Dose setting in in vivo mutagenicity assaysR J Fielder, J A Allen, A R Boobis, et al.

Neuro-Ophthalmology (Aeolus Press)|February 8, 2017

Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating PolyradiculoneuropathyS J Hickman, J A Allen, A Baisre, et al.

Cell Death and Differentiation|September 17, 2013

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesisS R Chan, C G Rickert, W Vermi, et al.

Pageof 9